Not Tagged
carsgen therapeutics
[]
carsgen presents results on anti-claudin18.2-mab ab011 at asco gi 
CARsgen Therapeutics is a clinical-stage immuno-oncology company committed to the development of First-in-Class & Best-in-Class CAR-T and antibody therapeutics.